Asia Pacific Diabetic Foot Ulcer Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
Market Introduction
APAC consists of five major countries namely China, India, Japan, South Korea, and Australia. The market is also evaluated for the Rest of APAC market. The region holds third-largest position for the diabetic foot ulcer treatment market at a global level. China is the fast-growing county in the Asia Pacific. The country still has many emerging and developing markets where patients don’t have access to basic wound care. Wound care and treatment in healthcare settings is expanding quickly and driven primarily by increasing awareness of the technique and its various applications. The increasing prevalence of diabetes has become a global public health concern worldwide. China ranks number one, with the highest number of people with diabetes. The prevalence of diabetes and diabetic complications increased alarmingly in the last few years. As per the WHO, almost 10% of all adults in China – about 110 million people – currently live with diabetes. The number is expected to increase to 150 million by 2040 – with major health, social and economic consequences. Environmental factors such as obesity, aging, diet, and physical activity; genetic factors; contributed in accelerating diabetes population. Rising research activities to introduce novel wound treatment products and burgeoning use of 3D printing in wound care management are the major factor driving the growth of the APAC diabetic foot ulcer treatment market.
In case of COVID-19, APAC is highly affected specially India. People are packing India's public hospitals, as many are unable to afford private ones that generally uphold higher standards of care. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact the Diabetic Foot Ulcer Treatment market for a short period of time. The focus on the wound care treatments is less as government and population in the region are more focused on the treatment of COVID 19. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. China is specifically facing issues that this epidemic has caused, leading to disruption of the supply chain, projected decreases in revenue and sales within all industries. As the visits to healthcare settings has declined in response to the pandemic to the regions like South Korea and Japan which has negative impact on the wound care industry. In India, shutdown of the entire transportation within the country, and many provinces are establishing border restrictions within the country. This has led to paralyzed supply chains for any industry in India. However, essential medical product supply is not restricted but the production has been affected due to restriction on number of staff working in the companies. As the vaccination progress, the demand for wound care products is expected to increase which will support the diabetic foot ulcer treatment market.
Get more information on this report :
Market Overview and Dynamics
The APAC diabetic foot ulcer treatment market is expected to grow from US$ 976.51 million in 2021 to US$ 1,723.22 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. Escalating prevalence of diabetes and related chronic wounds is expected to surge the market growth. Depending on time taken to heal, wounds can be classified as acute and chronic. Diabetes has emerged as one of the most impactful health emergencies of the region in the 21st century. Diabetes affects many parts of the body, particularly the feet. Diabetic foot ulcers are sores developed on feet; they can also develop from seemingly trivial injuries to the feet. Diabetic foot ulcers are the common causes of amputation due to diabetes. According to a report published in the International Journal of Endocrinology in 2017, ~15–25% of patients with diabetes are susceptible to foot ulcers during their lifetime. The risk of developing diabetic foot ulcers in patients diagnosed with diabetes is anticipated to be ~2%; however, in patients with a previous history of foot ulceration, this risk is expected to increase to 17–60% over the next three years. ~20% of hospital admissions in people with diabetes are because of foot ulcers. As there are continuous occurrences of injuries caused due to diabetes in low- and medium-income, and high-income countries, the demand for diabetic foot ulcer treatments is on rise across APAC region.
Key Market Segments
In terms of type, the advanced wound care dressings segment accounted for the largest share of the APAC diabetic foot ulcer treatment market in 2020. In terms of ulcer type, the neuro-ischemic ulcers segment held a larger market share of the APAC diabetic foot ulcer treatment market in 2020. Further, the hospitals segment held a larger share of the APAC diabetic foot ulcer treatment market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the APAC diabetic foot ulcer treatment market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Medline Industries, Inc.; MiMedx; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO.
Reasons to buy report
- To understand the APAC diabetic foot ulcer treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC diabetic foot ulcer treatment market
- Efficiently plan M&A and partnership deals in APAC diabetic foot ulcer treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC diabetic foot ulcer treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC Diabetic Foot Ulcer Treatment Market Segmentation
APAC Diabetic Foot Ulcer Treatment Market - By Type
- Advanced Wound Care Dressings
- Hydrogel Dressings
- Collagen Dressing
- Alginate Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Others
- Biologics
- Skin Grafts
- Growth Factors
- Therapy Device
- Negative Pressure Wound Therapy
- Ultrasound Therapy
APAC Diabetic Foot Ulcer Treatment Market - By Ulcer Type
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
APAC Diabetic Foot Ulcer Treatment Market - By End User
- Hospitals
- Ambulatory Surgery Centers
- Home Care
APAC Diabetic Foot Ulcer Treatment Market - By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of APAC
APAC Diabetic Foot Ulcer Treatment Market - Company Profiles
- 3M
- B. Braun Melsungen AG
- Cardinal Health Inc
- Coloplast Group
- ConvaTec Group Plc
- Medline Industries, Inc.
- MiMedx
- Mölnlycke Health Care AB.
- Organogenesis Inc.
- Smith & Nephew
- URGO
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Diabetic Foot Ulcer Treatment Market – By Type
1.3.2 APAC Diabetic Foot Ulcer Treatment Market – By Ulcer Type
1.3.3 APAC Diabetic Foot Ulcer Treatment Market – By End User
1.3.4 APAC Diabetic Foot Ulcer Treatment Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Diabetic Foot Ulcer Treatment Market– Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Diabetic Foot Ulcer Treatment Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Escalating Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surging Geriatric Population
5.2 Key Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Key Market Opportunities
5.3.1 Rising Research Activities to Introduce Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Burgeoning Use of 3D Printing in Wound Care Management
5.5 Impact Analysis
6. Diabetic Foot Ulcer Treatment Market – APAC Analysis
6.1 APAC Diabetic Foot Ulcer Treatment Marker Revenue Forecast and Analysis
7. APAC Diabetic Foot Ulcer Treatment Market Analysis – By Type
7.1 Overview
7.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Hydrogel Dressings
7.3.4.1 Overview
7.3.4.2 Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Hydrocolloids Dressing
7.3.7.1 Overview
7.3.7.2 Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Dressing
7.3.8.1 Overview
7.3.8.2 Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5.4 Ultrasound therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8. APAC Diabetic Foot Ulcer Treatment Market Analysis – By Ulcer Type
8.1 Overview
8.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9. APAC Diabetic Foot Ulcer Treatment Market– By End User
9.1 Overview
9.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Home Care
9.5.1 Overview
9.5.2 Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
10. APAC Diabetic Foot Ulcer Treatment Market – Country Analysis
10.1 APAC: Diabetic Foot Ulcer Treatment Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 APAC: Diabetic Foot Ulcer Treatment Market, by Country, 2020 & 2028 (%)
10.1.2.1 China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 China: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.1.2.1 China: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.1.2.2 China: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.1.2.3 China: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.1.3 China: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.1.4 China: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Japan: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.2.2.1 Japan: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.2.2.2 Japan: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.2.2.3 Japan: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.2.3 Japan: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.2.4 Japan: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
10.1.2.3 India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 India: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.3.2.1 India: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.3.2.2 India: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.3.2.3 India: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.3.3 India: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.3.4 India: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
10.1.2.4 Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Australia: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.4.2.1 Australia: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.4.2.2 Australia: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.4.2.3 Australia: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.4.3 Australia: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.4.4 Australia: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
10.1.2.5 South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2 South Korea: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.5.2.1 South Korea: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.5.2.2 South Korea: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.5.2.3 South Korea: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.5.3 South Korea: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.5.4 South Korea: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
10.1.2.6 Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)
10.1.2.6.2.1 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)
10.1.2.6.2.2 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)
10.1.2.6.2.3 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)
10.1.2.6.3 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.2.6.4 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on APAC Diabetic Foot Ulcer Treatment Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 ConvaTec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast Group
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun Melsungen AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Medline Industries, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cardinal Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Organogenesis Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Mölnlycke Health Care AB.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MiMedx
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 URGO
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Diabetic Foot Ulcer Treatment Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. China: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 5. China: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 6. China: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 7. China: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 12. Japan: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Japan: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. India: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. India: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 16. India: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 17. India: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 18. India: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 19. India: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Australia: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 21. Australia: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 22. Australia: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 23. Australia: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 24. Australia: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. South Korea: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 27. South Korea: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 28. South Korea: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 29. South Korea: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 30. South Korea: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 31. South Korea: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 38. Organic Developments Done By Companies
Table 39. Inorganic Developments Done By Companies
Table 40. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Diabetic Foot Ulcer Treatment Market Segmentation
Figure 2. APAC Diabetic Foot Ulcer Treatment Market – By Country
Figure 3. APAC Diabetic Foot Ulcer Treatment Market Overview
Figure 4. Advanced Wound Care Dressings Segment Held Largest Share of APAC Diabetic Foot Ulcer Treatment Market by Type
Figure 5. Japan to Show Significant Growth During Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. Expert Opinion
Figure 8. APAC Diabetic Foot Ulcer Treatment Market Impact Analysis of Driver and Restraints
Figure 9. APAC Diabetic Foot Ulcer Treatment Market – Revenue Forecast and Analysis
Figure 10. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)
Figure 11. APAC Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)
Figure 25. APAC Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)
Figure 29. APAC Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. APAC Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. APAC Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. APAC: Diabetic Foot Ulcer Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 33. APAC: Diabetic Foot Ulcer Treatment Market, by Country, 2020 & 2028 (%)
Figure 34. China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic on Diabetic Foot Ulcer Treatment Market in APAC Countries
- 3M
- B. Braun Melsungen AG
- Cardinal Health Inc
- Coloplast Group
- ConvaTec Group Plc
- Medline Industries, Inc.
- MiMedx
- Mölnlycke Health Care AB.
- Organogenesis Inc.
- Smith & Nephew
- URGO
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC diabetic foot ulcer treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in APAC diabetic foot ulcer treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the diabetic foot ulcer treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution